TFEB deficiency was found to impair the β-elemene-induced lysosomal degradation of GPX4, thereby suppressing the anticancer effects of β-elemene through the inhibition of ferroptosis in an orthotopic NSCLC model [29]. This evidence concerns the gene GPX4 and non-small cell lung carcinoma.